2026. In silico Design and Computational Assessment of Small-Molecule GLP-1R Agonist as a Possible Treatment for Obesity and Type 2 Diabetes. Tikrit Journal of Pharmaceutical Sciences. 20, 1 (Jun. 2026), 51–66. DOI:https://doi.org/10.25130/tjphs.2026.20.1.6.51.66.